MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.rec.2022.01.017

Медицинская библиотека · Revista espanola de cardiologia (English ed.) · 2022

Spanish Registry of Acute Aortic Syndrome (RESA). Changes in therapeutic management and lower mortality in acute aortic syndrome.

Evangelista Masip Artur, López-Sainz Ángela, Barros Membrilla Antonio José, Calvo Iglesias Francisco, López Ayerbe Jordi, Azqueta Molluna Manel, Mosquera Rodríguez Víctor X, Arregui Montoya Francisco, Tarrío Fernández Rubén, Revilla Orodea Ana, Sánchez Sánchez Violeta, Cantero Pérez Eva María, Ferrera Carlos, Toral Sepúlveda David, Nistal Francisco, Fernández Golfín Covadonga, Sao Augusto, Rodríguez-Palomares José, RESA centers

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION AND

OBJECTIVES

The Spanish Registry of Acute Aortic Syndrome (RESA) was launched in 2005 to identify the characteristics of acute aortic syndrome (AAS) in Spain. The aim of this study was to analyze the differences in management and mortality in the 3 RESA iterations.

METHODS

We analyzed data from patients with AAS prospectively included by 24 to 30 tertiary centers during the 3 iterations of the registry: RESA I (2005-2006), RESA-II (2012-2013), and RESA III (2018-2019).

RESULTS

AAS was diagnosed in 1902 patients (74% men; age, 60.7±12.5 years): 1329 (69.9%) type A and 573 (30.1%) type B. Comparison of the 3 periods revealed that the use of computed tomography increased as the first diagnostic technique (77.1%, 77.9%, and 84.2%, respectively; P=.001). In type A, surgical management increased (79.6%, 78.7%, and 84.5%; P=.045) and overall mortality decreased (41.2%, 34.5%, and 31.2%; P=.002), due to a reduction in surgical mortality (33.4%, 25.1%, and 23.9%; P=.003). In type B, endovascular treatment increased (22.8%, 32.8%, and 38.7%; P=.006), while medical and surgical treatment decreased. Overall type B mortality also decreased (21.6%, 16.1%, and 12.0%; P=.005) in line with a reduction in mortality with medical (16.8%, 13.8%, and 8.8%, P=.030) and endovascular (27.0%, 18.0%, and 9.2%; P=.009) treatments.

CONCLUSIONS

The iterations of RESA show a decrease in mortality from type A AAS, coinciding with an increase in surgical treatment and a reduction in surgical mortality. In type B, the use of endovascular treatment was associated with improved survival, allowing better management in patients with complications.

Для цитирования: Evangelista Masip Artur, López-Sainz Ángela, Barros Membrilla Antonio José, Calvo Iglesias Francisco, López Ayerbe Jordi, Azqueta Molluna Manel, Mosquera Rodríguez Víctor X, Arregui Montoya Francisco, Tarrío Fernández Rubén, Revilla Orodea Ana, Sánchez Sánchez Violeta, Cantero Pérez Eva María, Ferrera Carlos, Toral Sepúlveda David, Nistal Francisco, Fernández Golfín Covadonga, Sao Augusto, Rodríguez-Palomares José, RESA centers. Spanish Registry of Acute Aortic Syndrome (RESA). Changes in therapeutic management and lower mortality in acute aortic syndrome.. Revista espanola de cardiologia (English ed.). 2022. DOI: 10.1016/j.rec.2022.01.017.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.